Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Revenue (2020 - 2026)

Aveanna Healthcare Holdings' Revenue history spans 7 years, with the latest figure at $662.5 million for Q1 2026.

  • For Q1 2026, Revenue rose 27.43% year-over-year to $662.5 million; the TTM value through Jan 2026 reached $2.4 billion, up 20.19%, while the annual FY2026 figure was $2.4 billion, 20.19% up from the prior year.
  • Revenue reached $662.5 million in Q1 2026 per AVAH's latest filing, up from $621.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $662.5 million in Q1 2026 to a low of $443.0 million in Q3 2022.
  • Average Revenue over 5 years is $514.5 million, with a median of $490.7 million recorded in 2024.
  • Peak YoY movement for Revenue: fell 25.53% in 2022, then grew 27.43% in 2026.
  • A 5-year view of Revenue shows it stood at $451.1 million in 2022, then grew by 6.14% to $478.8 million in 2023, then increased by 8.57% to $519.9 million in 2024, then rose by 19.63% to $621.9 million in 2025, then increased by 6.52% to $662.5 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's Revenue are $662.5 million (Q1 2026), $621.9 million (Q3 2025), and $589.6 million (Q2 2025).